Sign Up Today and Learn More About Rgenix Stock

Invest in or calculate the value of your shares in Rgenix or other pre-IPO companies through EquityZen's platform.

Get Started

Rgenix Stock

Rgenix is a a discovery platform, revolutionizing the treatment of cancer by generating first-in-class therapeutics.

About Rgenix Stock




New York, NY, US

Total Funding


Rgenix is a a discovery platform, revolutionizing the treatment of cancer by generating first-in-class therapeutics that target key nodes in cancer progression. Its proprietary discovery platform is based on innovations in cancer biology that enable the identification and validation of novel post-transcriptionally regulated targets. Rgenix’s productive approach has yielded multiple novel targets to date across several cancer types for which the company is developing drugs, and its scientific approach has led to the discovery of novel therapeutic targets and first-in-class drugs for several cancer sub-types, including melanoma, colorectal cancer and triple-negative breast cancer, among others. Its aim is to discover and develop safe, effective, and commercially viable therapies that will transform the lives of cancer patients by treating metastatic disease. Rgenix was developed by founding scientists Dr. Sohail Tavazoie and Dr. Saeed Tavazoie. It was launched in 2010.

Rgenix Press Mentions

Stay in the know about the latest news on Rgenix

Rgenix Management

Leadership team at Rgenix


David Darst


Masoud Tavazoie

Locked Features

Join now and verify your accreditation status to gain access to:

  • Rgenix current valuation
  • Rgenix stock price
  • Available deals in Rgenix and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Rgenix stock?

Accredited investors can buy pre-IPO stock in companies like Rgenix through EquityZen funds. These investments are made available by existing Rgenix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Rgenix stock?

Shareholders can sell their Rgenix stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."